)
Tony Huang
President & Chief Executive Officer,
NeuCyte
Tony Huang is President and CEO of NeuCyte, a biotechnology company that focuses on developing treatments for those suffering from neurological and neurodegenerative disorders. NeuCyte develops translatable cell-based assays for modeling CNS-related disorders using patient-derived and genetically engineered neural cell types to discover novel therapeutics.
Tony obtained his Ph.D. in Biochemistry from Peking Union Medical College, and J.D. from the University of Michigan Law School. He received his post-doctoral trainings from the University of Colorado School of Medicine and Princeton University.